European canine lymphoma network consensus recommendations for reporting flow cytometry in canine hematopoietic neoplasms

Flow cytometry (FC) is assuming increasing importance in diagnosis in veterinary oncology. The European Canine Lymphoma Network (ECLN) is an international cooperation of different institutions working on canine lymphoma diagnosis and therapy. The ECLN panel of experts on FC has defined the issue of reporting FC on canine lymphoma and leukemia as their first hot topic, since a standardized report that includes all the important information is still lacking in veterinary medicine.

[1]  N. Shaw.  Data reporting , 2018, Computerization and Going Paperless in Canadian Primary Care.

[2]  E. Morello,et al.  Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma. , 2015, Veterinary and comparative oncology.

[3]  L. Marconato,et al.  The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership. , 2015, Veterinary and Comparative Oncology.

[4]  L. Aresu,et al.  Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma. , 2015, Veterinary and comparative oncology.

[5]  T. Kalina,et al.  Flow diagnostics essential code: A simple and brief format for the summary of leukemia phenotyping , 2014, Cytometry. Part B, Clinical cytometry.

[6]  A. Dietz,et al.  Strategies for improving the reporting of human immunophenotypes by flow cytometry , 2014, Journal of Immunotherapy for Cancer.

[7]  L. Aresu,et al.  CD44 in canine leukemia: analysis of mRNA and protein expression in peripheral blood. , 2014, Veterinary immunology and immunopathology.

[8]  M. Drigo,et al.  Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma. , 2014, Veterinary journal.

[9]  E. Mayson,et al.  CD5‐positive follicular lymphoma: prognostic significance of this aberrant marker? , 2014, Internal medicine journal.

[10]  Paul R. Avery,et al.  Canine T‐Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population Characteristics , 2014, Journal of veterinary internal medicine.

[11]  T. Kalina,et al.  Flow diagnostics essential (FDE) code: A simple and brief format for the summary of leukemia phenotyping: Flow Diagnostics Essential (FDE) Code , 2013 .

[12]  L. Marconato,et al.  Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value. , 2013, Veterinary journal.

[13]  M. Somerfield,et al.  American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Paul R. Avery,et al.  Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. , 2011, Journal of veterinary internal medicine.

[15]  M. Mazzilli,et al.  Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. , 2008, Veterinary immunology and immunopathology.

[16]  I. Schwendenwein,et al.  Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping. , 2007, Journal of comparative pathology.

[17]  S. Comazzi,et al.  Flow cytometric expression of common antigens CD18/CD45 in blood from dogs with lymphoid malignancies: a semi-quantitative study. , 2006, Veterinary immunology and immunopathology.

[18]  S. Pileri,et al.  Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Barber,et al.  Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. , 2005, Veterinary immunology and immunopathology.

[20]  C. Stewart,et al.  Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2003, American journal of clinical pathology.

[21]  A Orfao,et al.  Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation , 2002, Leukemia.

[22]  B. Bain,et al.  Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. , 2002, Clinical and laboratory haematology.

[23]  P. Moore,et al.  An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. , 1999, Veterinary immunology and immunopathology.

[24]  P. Ward,et al.  Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas. , 1999, Leukemia & lymphoma.

[25]  M. Borowitz,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, Maryland, November 16-17, 1995. , 1997, Cytometry.

[26]  J. Krejsek,et al.  Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells. , 2011, Neoplasma.

[27]  L. Marconato,et al.  Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia. , 2011, Journal of veterinary internal medicine.

[28]  Bruce Greig,et al.  2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia , 2007, Cytometry. Part B, Clinical cytometry.

[29]  G. Basso,et al.  Recommended reporting format for flow cytometry diagnosis of acute leukemia. , 2004, Haematologica.

[30]  C. Dunphy,et al.  CD30+ anaplastic large‐cell lymphoma with aberrant expression of CD13: Case report and review of the literature , 2000, Journal of clinical laboratory analysis.

[31]  R. Braylan,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. , 1997, Cytometry.